Aarti Drugs advanced 2.11% to Rs 405.80 after the pharmaceutical company's consolidated net profit rose 1.04% to Rs 37.05 crore in Q3 FY25, compared with Rs 36.67 crore recorded in Q3 FY24.

Kirloskar Pneumatic Company Limited declared an interim dividend of ₹3.50 per share for FY25, with a record date of February ...

Alexandria Real Estate Equities Inc. (NYSE:ARE), a leading real estate investment trust specializing in life sciences ...

Sysco Corporation (NYSE:SYY), the global leader in food distribution, finds itself at a critical juncture as it navigates a ...